Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk

Introduction. Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk. We have further analyzed the role of diabetes and antidiabetic treatments on HCC. Methods. Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC pati...

詳細記述

書誌詳細

出版年:	Gastroenterology Research and Practice
主要な著者:	Luca Miele, Cristina Bosetti, Federica Turati, Gianlodovico Rapaccini, Antonio Gasbarrini, Carlo La Vecchia, Stefania Boccia, Antonio Grieco
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2015-01-01
オンライン･アクセス:	http://dx.doi.org/10.1155/2015/570356